Starting ADHD medication: what the first three months involve

Starting medication for ADHD is a process with several steps, and knowing them in advance makes the early weeks less confusing. This article describes the usual shape of the first three months in general terms, and how New York's prescription rules fit around it. It contains no dosing information. Doses are set individually by the prescriber.

Before the first prescription

A prescription follows a diagnosis and a conversation about options. FDA labels for ADHD medications tell prescribers what to check first, and you can prepare for each item.

• Heart history. Stimulant labels call for a careful history, including any family history of sudden death or ventricular arrhythmia, and a physical exam. Know your family history before the visit.
• Mood history. Labels tell prescribers to screen for risk factors for a manic episode, such as a personal or family history of bipolar disorder or depression.
• Misuse risk. The boxed warning on stimulants tells prescribers to assess each patient's risk for abuse, misuse and addiction and to explain proper storage and disposal.
• Baseline measurements. A blood pressure and pulse reading taken before starting gives later readings something to be compared with.
• Other medications. Bring a complete list, including over-the-counter products and supplements.

Some prescribers also use a written treatment agreement for controlled substances. A 2024 review in American Family Physician advises controlled-substance agreements and prescription monitoring program checks as ways to watch for misuse or diversion. Being asked to sign one is routine.

The classes of medication a prescriber may discuss are set out in ADHD medications approved for adults in 2026.

Weeks 1 to 4: starting low and adjusting

The general approach is to begin at a starting dose and adjust in steps. Labels for example extended-release stimulant products describe adjusting at weekly intervals according to benefit and tolerability. The step-by-step process is called titration.

Your part in titration is observation. The prescriber can only adjust well with accurate reports. Keep brief daily notes on:

• what time you took the medication
• when you noticed an effect and when it wore off
• focus, task completion and restlessness, in your own words
• appetite and meals
• the time you fell asleep and how you slept
• mood, irritability or anxiety
• headache, dry mouth, nausea or a racing heartbeat
• blood pressure and pulse, if you have been asked to measure them

The side effects in that list are the ones adult trials reported most often. Current labels for example stimulant products list dry mouth, loss of appetite, insomnia, headache, nausea, anxiety and a fast heart rate among the most common adverse reactions in adults.

Take the medication exactly as prescribed during this period. Changing the dose or timing on your own makes your notes impossible to interpret, and with a monthly supply it can leave you short before the next fill is allowed.

Weeks 4 to 8: finding out whether it is working

By the second month the questions change from "can I tolerate this?" to "is this helping enough?" Useful evidence includes the daily notes, a symptom rating scale repeated from your evaluation, and observations from a partner or someone who knows you well.

Three outcomes are common at this stage, and all are normal parts of the process:

1. The medication helps and is tolerable, and the dose is kept where it is.
2. There is some benefit, and the prescriber adjusts the dose, the timing or the formulation.
3. The benefit is small or the side effects are not acceptable, and the prescriber suggests a different medication or class.

A change of medication does not mean treatment has failed. One stimulant label, for example, tells prescribers to stop the drug if improvement is not seen after appropriate dose adjustment over a one-month period, which is an instruction not to persist with a medication that is not helping.

Non-stimulants follow a similar pattern of stepped adjustment, with blood pressure and heart rate measured at baseline, after dose increases and periodically, according to the atomoxetine label.

Weeks 8 to 12: settling into maintenance

The large trials of ADHD medication in adults measured outcomes at about 12 weeks. In a 2018 analysis of those trials published in Lancet Psychiatry, amphetamines, methylphenidate and atomoxetine each reduced symptoms more than placebo over that period. Three months is therefore a sensible point for a fuller review:

• Which problems that brought you to evaluation have improved, and which have not?
• Are any side effects persisting?
• What have blood pressure and pulse readings shown?
• Is medication alone enough, or would skills-based work help? A Cochrane review found low-quality evidence that cognitive behavioral therapy added to medication may be beneficial in the short term.
• What will follow-up look like from here?

Medication trials say little about results beyond 12 weeks, so ongoing review is part of treatment. The first 90 days after an adult ADHD diagnosis covers the non-medication decisions that run alongside.

How New York's prescription cycle shapes the schedule

Stimulants are Schedule II controlled substances, and New York's rules create a rhythm that you will feel from the first month.

A dose change in the middle of a month means a new prescription and a new fill, which is one reason to raise problems at or before a scheduled contact instead of waiting.

As of October 2026, these visits can be held by video under federal rules that run through December 31, 2026. Check the position again before January 2027.

When to contact the prescriber between visits

Do not wait for the next appointment if you notice:

• chest pain, fainting or a pounding or irregular heartbeat (call 911 for chest pain or collapse)
• new or sharply worse anxiety, agitation or low mood
• seeing or hearing things that are not there, unusual suspiciousness, or a sustained high, driven mood with little need for sleep
• thoughts of harming yourself. Call or text 988 at any hour
• several nights of very poor sleep or a marked loss of appetite
• a strong urge to take more than prescribed

Stimulant labels note that these medications can, uncommonly, cause psychotic or manic symptoms in people with no prior history, and they tell prescribers to consider stopping the drug if that happens. Prompt reporting matters.

A checklist for the first visit after starting

• Your daily notes
• Blood pressure and pulse readings, with dates
• The date of your last fill and how many days of medication remain
• Your pharmacy's name and any stock problems it has reported
• Questions about side effects, timing and what happens next
• Any forms you need completed for work or school

For how medication management is organized in one adult ADHD practice, see adult ADHD treatment. Practical details about visits are on appointments and telehealth, and the new patients page explains how to begin.